Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes.

NCT00245297 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Haemophilia A

Interventions

DRUG: Kogenate FS, reconstituted in a suspension of liposomes

Sponsor

Recoly N.V.